BR9407799A
(pt)
|
1993-10-12 |
1997-05-06 |
Du Pont Merck Pharma |
Composição de matéria método de tratamento e composição farmaceutica
|
RU2153494C2
(ru)
|
1993-10-12 |
2000-07-27 |
Дзе Дюпон Мерк Фармасьютикал Компани |
1-n-алкил-n-арилпиримидинамины, способ лечения заболеваний, фармацевтическая композиция
|
DE69943247D1
(de)
|
1998-03-27 |
2011-04-14 |
Janssen Pharmaceutica Nv |
HIV hemmende Pyrimidin Derivate
|
US6458823B1
(en)
|
1998-06-08 |
2002-10-01 |
Wyeth |
Diaminopyrazoles
|
US6172222B1
(en)
|
1998-06-08 |
2001-01-09 |
American Home Products Corporation |
Diaminopyrazoles
|
OA11674A
(en)
|
1998-11-10 |
2005-01-12 |
Janssen Pharmaceutica Nv |
HIV Replication inhibiting pyrimidines.
|
MY133159A
(en)
|
1999-08-13 |
2007-10-31 |
Vertex Pharma |
Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
|
EA005423B1
(ru)
|
1999-09-24 |
2005-02-24 |
Янссен Фармацевтика Н.В. |
Противовирусные композиции
|
US6906067B2
(en)
|
1999-12-28 |
2005-06-14 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of TNF-α expression
|
ES2542326T3
(es)
|
2000-05-08 |
2015-08-04 |
Janssen Pharmaceutica Nv |
Inhibidores de la replicación del VIH
|
GB0016877D0
(en)
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Chemical compounds
|
GB0021726D0
(en)
|
2000-09-05 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
US7473691B2
(en)
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
AU2001292670A1
(en)
|
2000-09-15 |
2002-03-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US6613776B2
(en)
|
2000-09-15 |
2003-09-02 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
MXPA03005001A
(es)
|
2000-12-05 |
2003-09-05 |
Vertex Pharma |
Inhibidores de n- terminal c-jun cinasas (jnk) y otras proteinas cinasas.
|
US7122544B2
(en)
|
2000-12-06 |
2006-10-17 |
Signal Pharmaceuticals, Llc |
Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
|
ATE430742T1
(de)
|
2000-12-21 |
2009-05-15 |
Smithkline Beecham Corp |
Pyrimidinamine als angiogenesemodulatoren
|
BR0116411A
(pt)
|
2000-12-21 |
2003-11-11 |
Vertex Pharma |
Compostos de pirazol úteis como inibidores de proteìna cinase
|
JP4316893B2
(ja)
|
2001-05-16 |
2009-08-19 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Srcおよび他のプロテインキナーゼのインヒビター
|
RS94703A
(en)
|
2001-05-29 |
2007-02-05 |
Schering Aktiengesellschaft, |
Cdk inhibiting pyrimidines, production thereof and their use as medicaments
|
GB0113041D0
(en)
|
2001-05-30 |
2001-07-18 |
Astrazeneca Ab |
Chemical compounds
|
JP2005500294A
(ja)
|
2001-06-19 |
2005-01-06 |
ブリストル−マイヤーズ スクイブ カンパニー |
ホスホジエステラーゼ7に対するピリミジン阻害剤
|
WO2003000186A2
(en)
|
2001-06-21 |
2003-01-03 |
Ariad Pharmaceuticals, Inc. |
Novel phenylamino-pyrimidines and uses thereof
|
CA2451128A1
(en)
|
2001-06-26 |
2003-01-09 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of tnf-alpha expression
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
WO2003040141A1
(en)
|
2001-09-28 |
2003-05-15 |
Bayer Pharmaceuticals Corporation |
Oxazolyl-phenyl-2,4-diamino-pyrimidine compounds and methods for treating hyperproliferative disorders
|
EP2090571B1
(de)
|
2001-10-17 |
2012-05-16 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Pyrimidinderivate, Arzneimittel enthaltend diese Verbindungen, deren Verwendung und Verfahren zu ihrer Herstellung
|
EP1453516A2
(de)
|
2001-10-17 |
2004-09-08 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
5-substituierte 4-amino-2-phenylamino-pyrimdinderivate und ihre verwendung als beta-amyloid modulatoren
|
AU2002367172A1
(en)
|
2001-12-21 |
2003-07-15 |
Bayer Pharmaceuticals Corporation |
2,4-diamino-pyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
GB0205688D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
AU2003212282A1
(en)
*
|
2002-03-11 |
2003-09-22 |
Schering Aktiengesellschaft |
Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
|
US7288547B2
(en)
|
2002-03-11 |
2007-10-30 |
Schering Ag |
CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
|
AR039540A1
(es)
|
2002-05-13 |
2005-02-23 |
Tibotec Pharm Ltd |
Compuestos microbicidas con contenido de pirimidina o triazina
|
GB0211019D0
(en)
|
2002-05-14 |
2002-06-26 |
Syngenta Ltd |
Novel compounds
|
GB0215844D0
(en)
|
2002-07-09 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
EA200500721A1
(ru)
|
2002-11-28 |
2005-12-29 |
Шеринг Акциенгезельшафт |
Пиримидины, ингибирующие chk, pdk и акт, их получение и применение в качестве лекарственных средств
|
CA2514612A1
(en)
|
2003-01-30 |
2004-08-12 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
|
US7687531B2
(en)
|
2003-05-21 |
2010-03-30 |
Bayer Cropscience Ag |
Iodopyrazolyl carboxanilides
|
CA2531490A1
(en)
|
2003-07-15 |
2005-02-03 |
Neurogen Corporation |
Substituted pyrimidin-4-ylamina analogues as vanilloid receptor ligands
|
CN102358738A
(zh)
*
|
2003-07-30 |
2012-02-22 |
里格尔药品股份有限公司 |
2,4-嘧啶二胺化合物及其预防和治疗自体免疫疾病的用途
|
EP1648887A1
(en)
|
2003-07-30 |
2006-04-26 |
Cyclacel Limited |
Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors
|
DE602004032446D1
(de)
|
2003-08-07 |
2011-06-09 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidindiamin-verbindungen und verwendungen als antiproliferative mittel
|
DE10349423A1
(de)
|
2003-10-16 |
2005-06-16 |
Schering Ag |
Sulfoximinsubstituierte Parimidine als CDK- und/oder VEGF-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
|
GB0402653D0
(en)
|
2004-02-06 |
2004-03-10 |
Cyclacel Ltd |
Compounds
|
WO2005111016A1
(en)
|
2004-05-14 |
2005-11-24 |
Pfizer Products Inc. |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
CA2566531A1
(en)
|
2004-05-18 |
2005-12-15 |
Rigel Pharmaceuticals, Inc. |
Cycloalkyl substituted pyrimidinediamine compounds and their uses
|
EP1598343A1
(de)
|
2004-05-19 |
2005-11-23 |
Boehringer Ingelheim International GmbH |
2-Arylaminopyrimidine als PLK Inhibitoren
|
WO2006014482A1
(en)
|
2004-07-08 |
2006-02-09 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Pyrimidine derivatives useful as inhibitors of pkc-theta
|
US7521457B2
(en)
|
2004-08-20 |
2009-04-21 |
Boehringer Ingelheim International Gmbh |
Pyrimidines as PLK inhibitors
|
CA2578349A1
(en)
|
2004-09-01 |
2006-03-16 |
Rigel Pharmaceuticals, Inc. |
Synthesis of 2,4-pyrimidinediamine compounds
|
WO2006053109A1
(en)
|
2004-11-10 |
2006-05-18 |
Synta Pharmaceuticals Corp. |
Heteroaryl compounds
|
CA2584295C
(en)
|
2004-11-24 |
2014-08-26 |
Rigel Pharmaceuticals, Inc. |
Spiro-2, 4-pyrimidinediamine compounds and their uses
|
NZ555474A
(en)
|
2004-12-17 |
2010-10-29 |
Astrazeneca Ab |
4-(4-(imidazol-4-yl) pyrimidin-2-ylamino) benzamides as CDK inhibitors
|
EP1841760B1
(en)
|
2004-12-30 |
2011-08-10 |
Exelixis, Inc. |
Pyrimidine derivatives as kinase modulators and method of use
|
DE102005008310A1
(de)
|
2005-02-17 |
2006-08-24 |
Schering Ag |
Verwendung von CDKII Inhibitoren zur Fertilitätskontrolle
|
EP1705177A1
(en)
|
2005-03-23 |
2006-09-27 |
Schering Aktiengesellschaft |
N-aryl-sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agents
|
JP2008540391A
(ja)
*
|
2005-05-05 |
2008-11-20 |
アストラゼネカ アクチボラグ |
ピラゾリルアミノ置換ピリミジン、および癌の処置におけるそれらの使用
|
WO2006133426A2
(en)
|
2005-06-08 |
2006-12-14 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
CA2607901C
(en)
|
2005-06-13 |
2016-08-16 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for treating degenerative bone disorders using a syk inhibitory 2,4-pyrimidinediamine
|
US20060281712A1
(en)
|
2005-06-14 |
2006-12-14 |
Chi-Feng Yen |
Pyrimidine compounds
|
US20070032514A1
(en)
|
2005-07-01 |
2007-02-08 |
Zahn Stephan K |
2,4-diamino-pyrimidines as aurora inhibitors
|
WO2007023382A2
(en)
|
2005-08-25 |
2007-03-01 |
Pfizer Inc. |
Pyrimidine amino pyrazole compounds, potent kinase inhibitors
|
EA200800755A1
(ru)
|
2005-09-07 |
2008-10-30 |
Лаборатуар Сероно С.А. |
Ikk ингибиторы, предназначенные для лечения эндометриоза
|
EP1934200A1
(en)
*
|
2005-09-15 |
2008-06-25 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
DE102005048072A1
(de)
|
2005-09-24 |
2007-04-05 |
Bayer Cropscience Ag |
Thiazole als Fungizide
|
WO2007129195A2
(en)
|
2006-05-04 |
2007-11-15 |
Pfizer Products Inc. |
4-pyrimidine-5-amino-pyrazole compounds
|
PE20080068A1
(es)
|
2006-05-15 |
2008-03-17 |
Boehringer Ingelheim Int |
Compuestos derivados de pirimidina como inhibidores de la quinasa aurora
|
DE102006027156A1
(de)
|
2006-06-08 |
2007-12-13 |
Bayer Schering Pharma Ag |
Sulfimide als Proteinkinaseinhibitoren
|
MX2008016007A
(es)
|
2006-06-15 |
2009-01-16 |
Boehringer Ingelheim Int |
2-anilino-4-aminoalquilenoaminopirimidinas.
|
WO2007149789A2
(en)
|
2006-06-22 |
2007-12-27 |
Applera Corporation |
Conversion of target specific amplification to universal sequencing
|
WO2008016675A1
(en)
|
2006-08-01 |
2008-02-07 |
Praecis Pharmaceuticals Incorporated |
P38 kinase inhibitors
|
DE102006041382A1
(de)
|
2006-08-29 |
2008-03-20 |
Bayer Schering Pharma Ag |
Carbamoyl-Sulfoximide als Proteinkinaseinhibitoren
|
US20080194575A1
(en)
|
2006-10-04 |
2008-08-14 |
Naiara Beraza |
Treatment for non-alcoholic-steatohepatitis
|
EA200970512A1
(ru)
|
2006-11-27 |
2009-12-30 |
Арес Трейдинг С.А. |
Лечение по поводу множественной миеломы
|
AU2007333394C1
(en)
|
2006-12-08 |
2011-08-18 |
Novartis Ag |
Compounds and compositions as protein kinase inhibitors
|
GB0625196D0
(en)
|
2006-12-18 |
2007-01-24 |
7Tm Pharma As |
Modulators of cannabinoid receptor
|
WO2008079719A1
(en)
|
2006-12-19 |
2008-07-03 |
Genentech, Inc. |
Pyrimidine kinase inhibitors
|
EP1939185A1
(de)
|
2006-12-20 |
2008-07-02 |
Bayer Schering Pharma Aktiengesellschaft |
Neuartige Hetaryl-Phenylendiamin-Pyrimidine als Proteinkinaseinhibitoren zur Behandlung von Krebs
|
WO2008077885A2
(en)
|
2006-12-22 |
2008-07-03 |
Boehringer Ingelheim International Gmbh |
2- [(phenylamino) -pyrimidin-4ylamin0] -cyclopentane carboxamide derivatives and related compounds as inhibitors of kinases of the cell cycle for the treatment of cancer
|
EP2121633A2
(en)
|
2007-02-12 |
2009-11-25 |
Merck & Co., Inc. |
Piperazine derivatives for treatment of ad and related conditions
|
DE102007010801A1
(de)
|
2007-03-02 |
2008-09-04 |
Bayer Cropscience Ag |
Diaminopyrimidine als Fungizide
|
TW200846344A
(en)
|
2007-04-25 |
2008-12-01 |
Astrazeneca Ab |
Chemical compounds
|
MX2009013262A
(es)
|
2007-06-08 |
2010-01-25 |
Bayer Cropscience Sa |
Derivados de heterociclil-pirimidinil-amino fungicidas.
|
KR20100049068A
(ko)
|
2007-07-17 |
2010-05-11 |
리겔 파마슈티칼스, 인크. |
Pkc 억제제로서의 시클릭 아민 치환된 피리미딘디아민
|
EP2205603B1
(en)
|
2007-09-28 |
2014-01-15 |
Cyclacel Limited |
Pyrimidine derivatives as protein kinase inhibitors
|
JP5548130B2
(ja)
|
2007-10-09 |
2014-07-16 |
ダウ アグロサイエンシィズ エルエルシー |
殺虫性ピリミジニルアリールヒドラゾン
|
CA2704599C
(en)
|
2007-11-16 |
2015-05-12 |
Incyte Corporation |
4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
|
WO2009071535A1
(en)
|
2007-12-03 |
2009-06-11 |
Boehringer Ingelheim International Gmbh |
Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
|
CA2707989A1
(en)
|
2007-12-07 |
2009-06-11 |
Novartis Ag |
Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
|
NZ587589A
(en)
|
2008-02-15 |
2012-10-26 |
Rigel Pharmaceuticals Inc |
Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
|
CL2009000600A1
(es)
|
2008-03-20 |
2010-05-07 |
Bayer Cropscience Ag |
Uso de compuestos de diaminopirimidina como agentes fitosanitarios; compuestos de diaminopirimidina; su procedimiento de preparacion; agente que los contiene; procedimiento para la preparacion de dicho agente; y procedimiento para combatir plagas de animales y/u hongos dañinos patogenos de plantas.
|
US20100056524A1
(en)
|
2008-04-02 |
2010-03-04 |
Mciver Edward Giles |
Compound
|
WO2009127642A2
(en)
*
|
2008-04-15 |
2009-10-22 |
Cellzome Limited |
Use of lrrk2 inhibitors for neurodegenerative diseases
|
CA2723961C
(en)
|
2008-05-21 |
2017-03-21 |
Ariad Pharmaceuticals, Inc. |
Phosphorous derivatives as kinase inhibitors
|
US8445505B2
(en)
|
2008-06-25 |
2013-05-21 |
Irm Llc |
Pyrimidine derivatives as kinase inhibitors
|
UY31929A
(es)
|
2008-06-25 |
2010-01-05 |
Irm Llc |
Compuestos y composiciones como inhibidores de cinasa
|
US8716486B2
(en)
|
2008-06-25 |
2014-05-06 |
Edison Pharmaceuticals, Inc. |
2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
BRPI0911688A2
(pt)
|
2008-07-31 |
2015-07-28 |
Genentech Inc |
"compostos de pirimidina, composições e métodos de uso"
|
WO2010024430A1
(ja)
|
2008-09-01 |
2010-03-04 |
アステラス製薬株式会社 |
2,4-ジアミノピリミジン化合物
|
JP2012501981A
(ja)
|
2008-09-03 |
2012-01-26 |
バイエル・クロップサイエンス・アーゲー |
殺菌剤としてのヘテロ環置換アニリノピリミジン類
|
JP2012501983A
(ja)
|
2008-09-03 |
2012-01-26 |
バイエル・クロップサイエンス・アーゲー |
4−アルキル−置換ジアミノピリミジン類
|
US20100144722A1
(en)
|
2008-09-03 |
2010-06-10 |
Dr. Reddy's Laboratories Ltd. |
Novel heterocyclic compounds as gata modulators
|
WO2010025831A1
(de)
|
2008-09-03 |
2010-03-11 |
Bayer Cropscience Ag |
Heterozyklisch substituierte anilinopyrimidine als fungizide
|
EP2161259A1
(de)
|
2008-09-03 |
2010-03-10 |
Bayer CropScience AG |
4-Halogenalkylsubstituierte Diaminopyrimidine als Fungizide
|
TW201016676A
(en)
|
2008-10-03 |
2010-05-01 |
Astrazeneca Ab |
Heterocyclic derivatives and methods of use thereof
|
UY32240A
(es)
|
2008-11-14 |
2010-06-30 |
Boeringer Ingelheim Kg |
Nuevas 2,4-diaminopirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones.
|
GB0821307D0
(en)
|
2008-11-21 |
2008-12-31 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
EP3255047B1
(en)
|
2009-01-06 |
2021-06-30 |
Dana-Farber Cancer Institute, Inc. |
Pyrimido-diazepinone kinase scaffold compounds and uses in treating disorders
|
US20110071158A1
(en)
|
2009-03-18 |
2011-03-24 |
Boehringer Ingelheim International Gmbh |
New compounds
|
WO2010113834A1
(ja)
*
|
2009-03-30 |
2010-10-07 |
アステラス製薬株式会社 |
ピリミジン化合物
|
EP2419423A1
(en)
|
2009-04-14 |
2012-02-22 |
Cellzome Limited |
Fluoro substituted pyrimidine compounds as jak3 inhibitors
|
CN102482277B
(zh)
|
2009-05-05 |
2017-09-19 |
达纳-法伯癌症研究所有限公司 |
表皮生长因子受体抑制剂及治疗障碍的方法
|
TW201100441A
(en)
|
2009-06-01 |
2011-01-01 |
Osi Pharm Inc |
Amino pyrimidine anticancer compounds
|
US20120142667A1
(en)
|
2009-06-10 |
2012-06-07 |
Nigel Ramsden |
Pyrimidine derivatives as zap-70 inhibitors
|
EP2440548A1
(en)
*
|
2009-06-10 |
2012-04-18 |
Abbott Laboratories |
2- ( lh-pyrazol-4 -ylamino ) -pyrimidine as kinase inhibitors
|
AR077033A1
(es)
|
2009-06-11 |
2011-07-27 |
Hoffmann La Roche |
Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas
|
US20120172384A1
(en)
|
2009-06-18 |
2012-07-05 |
Mihiro Sunose |
Heterocyclylaminopyrimidines as kinase inhibitors
|
WO2010146132A1
(en)
|
2009-06-18 |
2010-12-23 |
Cellzome Limited |
Sulfonamides and sulfamides as zap-70 inhibitors
|
RU2012114902A
(ru)
|
2009-09-16 |
2013-10-27 |
Авила Терапьютикс, Инк. |
Конъюгаты и ингибиторы протеинкиназы
|
EA021437B1
(ru)
|
2009-09-29 |
2015-06-30 |
Глэксо Груп Лимитед |
Соединения, ингибирующие lrrk2 киназную активность
|
CA2780892C
(en)
|
2009-11-13 |
2017-02-14 |
Genosco |
Kinase inhibitors
|
SI2519543T1
(sl)
|
2009-12-29 |
2016-08-31 |
Emergent Product Development Seattle, Llc |
Beljakovine, ki se vežejo s heterodimeri in njihova uporaba
|
US8470820B2
(en)
|
2010-01-22 |
2013-06-25 |
Hoffman-La Roche Inc. |
Nitrogen-containing heteroaryl derivatives
|
CA2797947C
(en)
*
|
2010-06-04 |
2019-07-09 |
Charles Baker-Glenn |
Aminopyrimidine derivatives as lrrk2 modulators
|
BR112014011850B1
(pt)
*
|
2011-11-29 |
2022-01-11 |
Genentech, Inc |
Derivados de aminopirimidina, seus usos, e composição farmacêutica
|
CA2850705C
(en)
*
|
2011-11-29 |
2020-03-10 |
F. Hoffmann-La Roche Ag |
2-(phenyl or pyrid-3-yl)aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
|
AR089182A1
(es)
*
|
2011-11-29 |
2014-08-06 |
Hoffmann La Roche |
Derivados de aminopirimidina como moduladores de lrrk2
|
EP3121173A1
(en)
*
|
2011-11-29 |
2017-01-25 |
F. Hoffmann-La Roche AG |
Aminopyrimidine derivatives as lrrk2 modulators
|
BR112014012822A8
(pt)
*
|
2011-11-30 |
2017-07-11 |
Hoffmann La Roche |
Radioligantes rotulados com flúor-18 e carbono-11 para imagiologia por tomografia por emissão de pósitrons (pet) para lrrk2
|